 | Up a level |
Basaco, Tais; Pektor, Stefanie; Bermudez, Josue M.; Meneses, Niurka; Heller, Manfred; Galván, José A.; Frias Boligan, Kayluz; Schürch, Stefan; von Gunten, Stephan; Türler, Andreas; Miederer, Matthias (2018). Evaluation of Radiolabeled Girentuximab In Vitro and In Vivo. Pharmaceuticals, 11(4) MDPI 10.3390/ph11040132
Jenny, Lorenz; Dobó, József; Gál, Péter; Schroeder, Verena (2015). MASP-1 of the complement system promotes clotting via prothrombin activation. Molecular immunology, 65(2), pp. 398-405. Elsevier 10.1016/j.molimm.2015.02.014
Handrková, Helena; Borhany, M; Schroeder, Verena; Fatima, N; Hussain, A; Shamsi, T; Kohler, H P (2015). Identification of two novel missense mutations causing severe factor XIII deficiency. Haemophilia, 21(3), e253-e256. Blackwell Science 10.1111/hae.12663
Jenny, Lorenz; Ajjan, Ramzi; King, Rhodri; Thiel, Steffen; Schroeder, Verena (2015). Plasma Levels of MASP-1 and MASP-2 are Elevated in Type 1 Diabetes and Correlate with Glycaemic Control. Clinical and experimental immunology, 180(2), pp. 227-232. Blackwell Scientific Publications 10.1111/cei.12574
Schroeder, Verena; Handrková, Helena; Dodt, Johannes; Kohler, Hans-Peter (2015). Free factor XIII activation peptide affects factor XIII function. British journal of haematology, 168(5), pp. 757-759. Wiley-Blackwell 10.1111/bjh.13144
Heusser, Peter; Berger, S; Stutz, M; Hüsler, A; Häberli, André; Wolf, Ursula (2009). Efficacy of homeopathically potentized antimony on blood coagulation. A randomized placebo controlled crossover trial. Forschende Komplementärmedizin, 16(1), pp. 14-18. Basel: Karger 10.1159/000196974
Zeerleder, Sacha; Schroeder, Verena; Lämmle, Bernhard; Wuillemin, Walter A; Hack, C Erik; Kohler, Hans Peter (2007). Factor XIII in severe sepsis and septic shock. Thrombosis research, 119(3), pp. 311-318. Amsterdam: Elsevier 10.1016/j.thromres.2006.02.003
Banz, Yara; Hess, Otto M; Robson, Simon C; Csizmadia, Eva; Mettler, Daniel; Meier, Pascal; Haeberli, André; Shaw, Sidney; Smith, Richard A; Rieben, Robert (2007). Attenuation of myocardial reperfusion injury in pigs by Mirococept, a membrane-targeted complement inhibitor derived from human CR1. Cardiovascular research, 76(3), pp. 482-93. Oxford: Elsevier Ltd. 10.1016/j.cardiores.2007.07.016
Schroeder, Verena; Borner, Urs; Gutknecht, Stefan; Schmid, Jean-Paul; Saner, Hugo; Kohler, Hans P (2007). Relation of depression to various markers of coagulation and fibrinolysis in patients with and without coronary artery disease. European journal of cardiovascular prevention & rehabilitation, 14(6), pp. 782-787. Los Angeles, Calif.: Sage 10.1097/HJR.0b013e32828622e8
Ivaskevicius, V; Windyga, J; Baran, B; Schroeder, V; Junen, J; Bykowska, K; Seifried, E; Kohler, H P; Oldenburg, J (2007). Phenotype-genotype correlation in eight Polish patients with inherited Factor XIII deficiency: identification of three novel mutations. Haemophilia, 13(5), pp. 649-657. Oxford: Blackwell Science 10.1111/j.1365-2516.2007.01517.x
Ivaskevicius, V; Seitz, R; Kohler, HP; Schroeder, V; Muszbek, L; Ariens, RA; Seifried, E; Oldenburg, J; Study, Group (2007). International registry on factor XIII deficiency: a basis formed mostly on European data. Thrombosis and haemostasis, 97(6), pp. 914-921. Stuttgart: Schattauer 10.1160/TH07-01-0034
Schroeder, Verena; Vuissoz, Jean-Marc; Caflisch, Amedeo; Kohler, Hans P (2007). Factor XIII activation peptide is released into plasma upon cleavage by thrombin and shows a different structure compared to its bound form. Thrombosis and haemostasis, 97(6), pp. 890-898. Stuttgart: Schattauer 10.1160/TH06-08-0458
Schroeder, Verena; Meili, Esther; Cung, Trinh; Schmutz, Peter; Kohler, Hans P (2006). Characterisation of six novel A-subunit mutations leading to congenital factor XIII deficiency and molecular analysis of the first diagnosed patient with this rare bleeding disorder. Thrombosis and haemostasis, 95(1), pp. 77-84. Stuttgart: Schattauer 10.1160/TH05-06-0388
Zeerleder, Sacha; Schroeder, Verena; Hack, C Erik; Kohler, Hans Peter; Wuillemin, Walter A (2006). TAFI and PAI-1 levels in human sepsis. Thrombosis research, 118(2), pp. 205-212. Amsterdam: Elsevier 10.1016/j.thromres.2005.06.007
Schroeder, Verena; Wilmer, Marianne; Buehler, Beatrice; Kohler, Hans P (2006). TAFI activity in coronary artery disease: a contribution to the current discussion on TAFI assays. Thrombosis and haemostasis, 96(2), pp. 236-237. Stuttgart: Schattauer 10.1106/TH06-06-0295
Banz, Yara; Hess, Otto M; Robson, Simon C; Mettler, Daniel; Meier, Pascal; Haeberli, André; Csizmadia, Eva; Korchagina, Elena Y; Bovin, Nicolai V; Rieben, Robert (2005). Locally targeted cytoprotection with dextran sulfate attenuates experimental porcine myocardial ischaemia/reperfusion injury. European Heart Journal, 26(21), pp. 2334-43. Oxford: Oxford University Press 10.1093/eurheartj/ehi421
